Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly

Prostate cancer treatment is a significant source of morbidity and spending. Some men with prostate cancer, particularly those with significant health problems, are unlikely to benefit from treatment. To assess relationships between financial incentives associated with urologist ownership of radiati...

Full description

Saved in:
Bibliographic Details
Published in:European urology 2018-04, Vol.73 (4), p.491-498
Main Authors: Hollenbeck, Brent K., Kaufman, Samuel R., Yan, Phyllis, Herrel, Lindsey A., Borza, Tudor, Schroeck, Florian R., Jacobs, Bruce L., Skolarus, Ted A., Shahinian, Vahakn B.
Format: Article
Language:English
Subjects:
Aged
Cancer
Cohort Studies
Humans
Male
Medicare - statistics & numerical data
Patient Care Management - economics
Patient Care Management - methods
Patient Care Management - statistics & numerical data
Practice Management, Medical - organization & administration
Prostate
Prostatic Neoplasms - economics
Prostatic Neoplasms - epidemiology
Prostatic Neoplasms - therapy
Radiotherapy, Intensity-Modulated - methods
Radiotherapy, Intensity-Modulated - statistics & numerical data
Retrospective Studies
SEER Program - statistics & numerical data
Treatment
United States - epidemiology
Urology - methods
Urology - organization & administration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prostate cancer treatment is a significant source of morbidity and spending. Some men with prostate cancer, particularly those with significant health problems, are unlikely to benefit from treatment. To assess relationships between financial incentives associated with urologist ownership of radiation facilities and treatment for prostate cancer. A retrospective cohort of Medicare beneficiaries with prostate cancer diagnosed between 2010 and 2012. Patients were further classified by their risk of dying from noncancer causes in the 10 yr following their cancer diagnosis by using a mortality model derived from comparable patients known to be cancer-free. Urologists were categorized by their practice affiliation (single-specialty groups by size, multispecialty group) and ownership of a radiation facility. Use of intensity-modulated radiation therapy (IMRT) and use of any treatment within 1 yr of diagnosis. Generalized estimating equations were used to adjust for patient differences. Among men with newly diagnosed prostate cancer, use of IMRT ranged from 24% in multispecialty groups to 37% in large urology groups (p
ISSN:0302-2838
1873-7560
DOI:10.1016/j.eururo.2017.08.001